Feeds:
Posts
Comments

Posts Tagged ‘Harris Corp’

A few months ago, we noted that the release of regulations for ACOs would trigger an ACO services race across the healthcare landscape, where market participants would be sprinting to create service offerings that would help hospitals and physician practices become compliant with the CMS ACO regulations for sharing financial risk and the rewards.  So where do things stand six months later?

Just like earlier this year, the “Big Two” – Optum and Aetna – seem to be squarely in the lead of creating a turnkey ACO solution.  And in the last few weeks, we’ve seen a couple items of note from these two.  The first was an interview with Charles Kennedy, CEO of Aetna’s ACO division on HISTalk.  In the interview, Kennedy talks about how Aetna is pursuing the ACO opportunity via three go-to-market offerings:

  • Clinical integration (basically an HIE via Medicity)
  • A population-based approach with chronic disease management tools that typically rolls out to hospital employees as a way of deploying a light version of an ACO
  • A full, private-label health plan, where a delivery system has their own health plan “powered by Aetna”

Last week, Optum announced that it has brought together its own ACO division with more than 700 people (!) focused on enabling “Sustainable Health Communities,” which is Optum’s version of the ACO concept.  Optum’s press release calls out its own five-part strategy:

  • Patient and population health management
  • Informatics, analytics, and technology
  • Clinical integration, network development, and physician change management
  • Payment model, contracting, and actuarial expertise
  • Operating expertise

Interestingly, the press release also mentions that Optum is also bringing solutions to market targeted at commercial health plans and government payers – the other side of the ACO/shared risk/bundled payment equation.

The big question we have been trying to figure out here at TripleTree is who is going to follow “the Big Two” and their industry-leading ACO partnership announcements (specifically: Optum with Tuscon Medical Center and Aetna with Carilion Clinic)?  Where are the other healthcare companies that are going to pursue this mammoth opportunity?  Wellpoint’s acquisition of CareMore, McKesson’s acquisition of Portico, and Harris Corporation’s acquisition of Carefx certainly point to their interest in this market, as does Premier’s burgeoning alliance with IBM – but we have yet to see any of these or other players signal their interest in developing a broader set of provider-focused bundled payment service offerings.

This past week we think have finally seen another company unequivocally throwing its hat in the ring:  The Advisory Board Company announced the creation of a new company called Evolent Health, in partnership with the UPMC Health Plan.  Evolent intends to provide a platform for population and health plan management to leading health systems as they develop their value-based care strategies.  This follows ABCO’s earlier acquisitions of Crimson, Concuity, and Cielo MedSolutions – all earlier signals that the company was pursuing the hospital analytics, contracting, and registry marketplaces in a big way.

It makes perfect sense for The Advisory Board to do this – with nearly unparalled access to hospital c-suites across the country, it was only a matter of time before they launched a solution to address the many, many requests they must be getting to help with hospitals’ new risk-sharing strategies.  We see this as a welcome development in this space, and hope to see other HCIT players, undoubtedly facing their own questions from their healthcare clients, enter the fray as well.  Where are you, Accenture, Microsoft, and Elsevier?

Let us know what you think.

Conor Green

Conor Green is a Vice President at TripleTree covering the healthcare industry, and specializing in revenue cycle management and tech-enabled business services. You can email Conor at cgreen@triple-tree.com.

Read Full Post »

National defense spending is facing headwinds as the Department of Defense controller predicts the national defense budget to decline from its current level of $740 billion to $700 billion in 2012; and $650 billion in 2013.

For defense contractors reliant on this spending, TripleTree expects a continued focus on vertical expansion to intensify as early adopters expand on their existing footprints and late-comers feel the pressure to aggressively stimulate growth at any cost.

We predict that 2012 will be an active year in federal healthcare M&A because of four factors:

  • Military deployment drawdown and DoD budget cuts
  • Documented success of early healthcare initiative adopters
  • Fear of stockholder retribution by late-movers
  • Looming 2013 healthcare initiative deadlines mandated by the Affordable Care Act.

With that in mind, large contractors continue to trumpet new healthcare initiatives, redirect strategy teams, appoint new management, and realign spending priorities. Recent announcements underscore the trend:

  • CGI Group will record health care revenue as a separate vertical segment going forward. Behind this move was strong historical performance ($350 million in annual revenue), high growth (3 year healthcare CAGR of 28.1% vs. 5.3% for CGI), and strategic importance (order backlog of more than $1.2 billion)
  • USIS will form a healthcare solutions group providing fraud, waste, & abuse services targeting the federal market. The move reflects a strategic departure from its traditional business providing background investigations and screenings
  • Harris Corporation was awarded over a quarter of a billion dollars of healthcare contracts in the past 45 days – healthcare is part of the company’s fastest growing business segment
  • CACI International President & CEO Paul Cofoni announced on the heels of winning four HCIT contract awards worth a cumulative $69 million that “transformative healthcare IT solutions and services … are key components of our future growth strategy”
  • Pure play defense & IT contractors continue to woefully underperform their diversifying peers – Raytheon lowered its sales forecast by $500 million to $1 billion

Last quarter we predicted M&A activity would be carried on the backs of public asset divestitures, private equity platform transactions, and contract vehicle access acquisitions, or “golden tickets”. To that point, in the past three months we have seen a handful of corporate divestitures, including the spinout of SRA’s CRO division to biopharmaceutical company Aptiv Solutions. We’ve also watched as a near-record number of small government vendor acquisitions have occurred (71 last year, the highest since 2000), and at least one “golden ticket” transaction went down (ManTech’s $90 million purchase of Worldwide Information Network Systems, a cyber IT provider). Last week, consulting firm Grant Thornton acquired Computer Technology Associates’ Health Solutions division, expanding its healthcare and public sector presence with five military healthcare contracts.

Healthcare is not a sector that lends itself to being understood swiftly and easily and much of the hesitation from non-traditional global acquirers in diversifying into healthcare stems from this lack of familiarity. Contractor expansion into the healthcare vertical has been slower and more deliberate than peer verticals like cyber security and intelligence. We believe that contractor healthcare strategy teams are nearing the end of their incubation periods and once committed to healthcare, their business models and-go-to market approaches will be fully baked. Federal contractor healthcare initiatives will be key area of our research agenda and advisory focus in the quarters ahead, and we’ll opine often on developments…until then, let us know what you think.

Marc Baudry

Marc Baudry is an analyst at TripleTree covering the healthcare industry specializing in government health, population health management, informatics, and facility-based services. Follow Marc on Twitter or email him at mbaudry@triple-tree.com.

Read Full Post »

The U.S. healthcare industry is undoubtedly going through one of the most pronounced transformations in its history.  At the most fundamental level, the means and methods by which patients, providers, and payers interact is changing dramatically.

  • Consumers (patients) are increasingly at the epicenter of the healthcare delivery and decision making processes.
  • Providers (hospitals, clinics) are mobilizing to take advantage of new delivery models that assume the accountability for the quality and cost of healthcare for a defined population, the long-term goal of the ARRA legislation (health reform).
  • Payers (health plans) are expanding their focus beyond a traditional coverage and benefits orientation to include advanced health management and decision support capabilities.

For innovators and investors, these structural changes in conjunction with the ongoing trend toward more granular clinical documentation and code sets (i.e., the new HIPAA 5010 standards and transition from ICD-9 to ICD-10) as well as the lure of billions in financial incentives related to complying with HITECH/Meaningful Use rules are creating brittle calculus for valuing technological advancement and innovation.

In many respects the U.S. health system has been caught flat-footed by a wave of long-overdue regulatory mandates aimed at dragging an industry long resistant to change into the twenty-first century.  The impending need for innovative healthcare IT solutions has created substantial demand for forward-looking vendors with the capability to provide greater efficiency and quality within the care delivery continuum and/or improve transparency within healthcare’s convoluted reimbursement system.  Companies with these general characteristics are rare and truly valuable.

When taken together, the combination of pent-up demand and a scarcity of viable alternatives create a “bubble-like” atmosphere where valuations have crept well outside their historical bounds.  Leading healthcare IT vendors are experiencing unprecedented interest from a range of potential acquirers that fall into three broad categories:

The flurry of activity has resulted in a sellers’ market in which revenue multiples (computed as enterprise value divided by trailing twelve months revenue) have exceeded 8-9x.  This begs the question: is healthcare IT in a bubble?  The answer would be unequivocally “yes” if it weren’t for a range of trends that will persist for the next 10-20 years:

  • 78 million Baby Boomers are reaching retirement age
  • Over-utilization and high cost prescription drugs and medical procedures are not proving to be cost-effective
  • Increasing incidence and complexity of chronic and co-morbid conditions.
  • Healthcare, as compared to most other industries is in infancy in terms of technology adoption – creating a long-standing demand for IT implementation, integration, and optimization
  • Need for new and creative approaches to funding the rising cost of healthcare in light of the strain put on the Medicare and Medicaid entitlement programs
  • Prevalence of fraud, waste, and abuse within the administration and reimbursement processes

A constantly replenishing pipeline of new, entrepreneurial companies is fueling the pioneering spirit and innovation required to advance and redefine the U.S. healthcare system.  Any resemblance to a “bubble” is snuffed out by the sustainability of the current demand and expanding interest from the nation’s leading entrepreneurs, business builders, investors, and advisors that will continue to be attracted to solving healthcare’s complex, long-standing problems.  All in all, it’s a great time to be an innovator in healthcare.

Let us know what you think.

Seth Kneller

Seth Kneller is an Associate at TripleTree covering the healthcare industry, specializing in revenue cycle management, clinical software solutions, geriatric care and healthcare analytics. Follow Seth on Twitter or e-mail him at skneller@triple-tree.com.

Read Full Post »